Abiogen Pharma , a leading pharmaceutical company based in Pisa with 168 million in revenue and 460 employees (2024 data), specializing primarily in bone metabolism, pain treatment, and respiratory, metabolic (diabetes), and dermatological disorders, announces the achievement of the Gender Equality Certification, in compliance with UNI/PdR 125:2022 practice, the national reference standard.
The recognition, issued by the accredited body CSQA Certificazioni and officially presented today, Monday, February 2nd, at the company headquarters, is the result of a rigorous audit process conducted with the strategic support of the Unione Industriale Pisana , aimed at evaluating policies, processes, and performance indicators related to equity and inclusion.
The certification confirms Abiogen Pharma's concrete and ongoing commitment to promoting an internal culture based on respect for people, talent development, and fair and transparent opportunities.
With a female presence equal to 50% of the workforce , the company has over time developed an organizational model attentive to the well-being of its resources, supported by a structured welfare system, work-life balance policies and merit-oriented professional growth paths.
" The Gender Equality Certification is an important recognition for us and, above all, an incentive to continue with even greater determination along the path we have taken, " says Massimo Di Martino , president of Abiogen Pharma . " The valorization of people, regardless of gender, is a strategic factor for the company's sustainable growth and for the quality of decision-making processes, in a highly skilled sector like the chemical-pharmaceutical one ."
[…]
Source: T24 Economy